Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol + zofenopril versus monotherapy in grade 1-2 hypertension
2020-002340-23Phase 4Completed
- Sponsor
- Menarini Group
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nebivolol and zofenopril in hypertension (HTN) (3 arms), sponsored by Menarini Group. Primary endpoint: Change in mean sitting diastolic blood pressure. Started Jun 2021; status: completed.
02
Drugs
nebivololzofenopril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2020-002340-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002340-23.